Thailand begins Covid-19 vaccine rollout using Astrazeneca shots made by Siam BioScience
CNNBangkok CNN — Thailand began its mass Covid vaccination program Monday, following criticism of delays and concerns over health authorities relying on AstraZeneca shots produced by a company owned by the country’s king. Madaree Tohlala/AFP/Getty Images Meanwhile, the Philippines said on June 1 delivery of the first batches of an order of 17 million doses of the AstraZeneca vaccine produced by Siam BioScience was delayed and reduced, according to Reuters. He also criticized the government for relying on just one vaccine supplier, AstraZeneca, which subsequently selected Siam BioScience, owned by King Maha Vajiralongkorn, to be their main producer in Southeast Asia last year. Thailand’s disease control department said as of June 7 there were 2.04 million AstraZeneca doses and 1.5 million Sinovac doses available in the country.